RESHAPE: REVERSE-EDITED SYNTHETIC HYPOTHESES FOR AUTOMATIC POST-EDITING



A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents

Ghada M El Sagheer,1 Asmaa K Ahmad,1 Aliaa S Abd-ElFattah,1 Zienab M Saad,2 Lamia Hamdi3 1Internal Medicine Department, Endocrinology Unit, 2Hepatology Department; 3Clinical Pathology Department, Minia University, El-Minia, Egypt Background: Fibroblast growth factor (FGF) 21 was reported to selle chromag overture be induced by different injurious a

read more